Live search
TopFind is fetching the latest matches for your search.
We reviewed 6 live results for abraxane and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Chemotherapy and Oncology.
Source: Bristol Myers Squibb (Singapore)
Description
Abraxane is a registered chemotherapy medication consisting of albumin-bound paclitaxel (nab-paclitaxel) for intravenous injection. This nanoparticle technology allows for more effective delivery of paclitaxel to cancer cells. It is primarily used in oncology for treating metastatic breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer. In Singapore, it is listed on the National Drug Formulary and the MediShield Life Outpatient Cancer Drug List for specific subsidised indications.
Best for
metastatic breast cancer patients, pancreatic cancer treatment, non-small cell lung cancer and oncology patients in Singapore
Rating
Source: Bristol-Myers Squibb (BMS) Malaysia
Description
A specialized formulation of paclitaxel protein-bound particles for injectable suspension. It is registered in Malaysia for the treatment of metastatic breast cancer and pancreatic adenocarcinoma.
Best for
metastatic breast cancer, pancreatic adenocarcinoma and albumin-bound chemotherapy
Rating
Source: Tan Tock Seng Hospital (TTSH) Pharmacy
Description
Administration of Abraxane via intravenous injection within a clinical hospital setting. Services include specialist consultation, pharmacy supply, and patient medication guides for breast, pancreas, and lung cancer treatments. As a public institution, TTSH supports subsidised healthcare through the National Drug Formulary.
Best for
subsidised healthcare seekers, public hospital patients and oncology medication guidance
Rating
| Compare | Abraxane (nab-paclitaxel) 100mg/vial | Abraxane | Nab-paclitaxel (Abraxane) Administration |
|---|---|---|---|
| Source | Bristol Myers Squibb (Singapore) | Bristol-Myers Squibb (BMS) Malaysia | Tan Tock Seng Hospital (TTSH) Pharmacy |
| Description | Abraxane is a registered chemotherapy medication consisting of albumin-bound paclitaxel (nab-paclitaxel) for intravenous injection. This nanoparticle technology allows for more effective delivery of paclitaxel to cancer cells. It is primarily used in oncology for treating metastatic breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer. In Singapore, it is listed on the National Drug Formulary and the MediShield Life Outpatient Cancer Drug List for specific subsidised indications. | A specialized formulation of paclitaxel protein-bound particles for injectable suspension. It is registered in Malaysia for the treatment of metastatic breast cancer and pancreatic adenocarcinoma. | Administration of Abraxane via intravenous injection within a clinical hospital setting. Services include specialist consultation, pharmacy supply, and patient medication guides for breast, pancreas, and lung cancer treatments. As a public institution, TTSH supports subsidised healthcare through the National Drug Formulary. |
| Best for | metastatic breast cancer patients, pancreatic cancer treatment, non-small cell lung cancer and oncology patients in Singapore | metastatic breast cancer, pancreatic adenocarcinoma and albumin-bound chemotherapy | subsidised healthcare seekers, public hospital patients and oncology medication guidance |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Abraxane (nab-paclitaxel) 100mg/vial from Bristol Myers Squibb (Singapore)."
I picked this because This is the official therapeutic product registered in Singapore, essential for oncology patients requiring nanoparticle albumin-bound paclitaxel chemotherapy.